Lin C, Wu H, Xian W, Zheng Y, Du W, Chen X, Li J, Chen W, Lin L, Su F, Pei Z, Liu G, EPAD Consortium EPAD Consortium. Deep learning enhanced ALPS reveals genetic and environmental factors of brain glymphatic function. EBioMedicine. 2026 124:106133.
Merkel J, Perneczky R, Jessen F, Frölich L, Jansen O, Peters S, Berg D, Schulz JB, Bartsch T. Amyloid-related imaging abnormalities (ARIA) in Alzheimer's disease: from pathophysiology to individualized risk assessment. Alzheimers Res Ther. 2026 Mar 28. [Epub ahead of print]
Perry R, Kipps C, Soto Martín ME, Bozzali M, Logroscino G, Trafford S, Dhadda S, Kanekiyo M, Goodwin A, Hodgkinson M, Hersch S, Irizarry M, Kramer L, Frölich L. Lecanemab for treatment of individuals with early Alzheimer's Disease (AD) who are apolipoprotein E ε4 (ApoE ε4) non-carriers or heterozygotes. J Prev Alzheimers Dis. 2026 13(4):100507. Epub 2026 Feb 13.
Wischik CM, Stefanacci R, Bentham P, Gauthier S, Zetterberg H, Wilcock GK, Frölich L, Burns A, MacSweeney E, Ballard C, Yu JT, Choon TS, Asvatourian V, Muehlemann N, Priel J, Kook K, Sullivan T, Downie D, Miller S, Pringle C, Storey JMD, Baddeley T, Harrington CR, Penny LK, Arastoo M, Staff R, Sandu AL, Shiells H, Lo S, Nazlee N, Evans E, Hull C, Schelter BO. Clinical, imaging and blood biomarker outcomes in a Phase 3 clinical trial of tau aggregation inhibitor hydromethylthionine mesylate in mild cognitive impairment and mild to moderate dementia due to Alzheimer's disease. J Prev Alzheimers Dis. 2026 13(3):100480. Epub 2026 Jan 21.
van der Veere PJ, van Harten AC, van Maurik IS, Teunissen CE, Barkhof F, Vos SJ, Frölich L, Kornhuber J, Wiltfang J, Maier W, Peters O, Rüther E, Frisoni GB, Spiru L, Freund-Levi Y, Wallin AK, Hampel H, Tsolaki M, Kłoszewska I, Mecocci P, Vellas B, Lovestone S, Galluzzi S, Herukka SK, Santana I, Baldeiras I, de Mendonça A, Silva D, Chetelat G, Poisnel G, Visser PJ, Johnson SC, Stormrud E, Hansson O, Palmqvist S, Piñol-Ripoll G, Reichl MR, Berkhof J, van der Flier WM. Revising the ABIDE MCI to dementia prediction model for automated cerebrospinal fluid assays. Alzheimers Dement. 2026 22(2):e71192.